TY  - JOUR
AU  - Guo, Feifei
AU  - Estévez Vázquez, Olga
AU  - Benede Ubieto, Raquel
AU  - Lamas Paz, Arantza
AU  - Gómez Del Moral Martín-Consuegra, Manuel María
AU  - Vaquero Martín, Francisco Javier
AU  - Regueiro González-Barros, José Ramón
AU  - Bañares Cañizares, Rafael
AU  - Cubero Palero, Francisco Javier
AU  - Nevzorova, Yulia
PY  - 2021
DO  - 10.3390/cancers14010192
UR  - https://hdl.handle.net/20.500.14352/107411
T2  - Cancers
AB  - Background: Metabolic-associated fatty liver disease (MAFLD) has risen as one of the leading etiologies for hepatocellular carcinoma (HCC). Oncogenes have been suggested to be responsible for the high risk of MAFLD-related HCC. We analyzed the impact...
LA  - eng
M2  - 192
PB  - MDPI
KW  - metabolic-associated fatty liver disease (MAFLD)
KW  - c-myc
KW  - oncogene
KW  - tumorigenesis
KW  - metformin
TI  - A shortcut from Metabolic-Associated Fatty Liver Disease (MAFLD) to hepatocellular carcinoma (HCC) c-MYC as a promising target for preventative strategies and individualized therapy.
TY  - journal article
VL  - 14
ER  -